A Discussion About the 2012 ADA/EASD Position Statement
Dr. Doron Schneider and Dr. Jack Leahy discuss the 2012 ADA/EASD position statement on management of type 2 diabetes and its implications to clinical care.
Dr. Doron Schneider and Dr. Jack Leahy discuss the 2012 ADA/EASD position statement on management of type 2 diabetes and its implications to clinical care.
In the past decade or so, our attempts to define the "earliest” events in Type 2 diabetes (T2DM) have moved increasingly earlier. We’re considering even the years before what we now consider to be the “pre-diabetes” stage—that is, years considerably before there are any clinical signs or symptoms of disease.